OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)
Titel:
OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)
Auteur:
Lonial, Sagar Richardson, Paul G. Popat, Rakesh Stadtmauer, Edward A. Larsen, Jeremy T. Oriol, A. Knop, Stefan Jagannath, Sundar Cook, Gordon Badros, Ashraf Z. RodrÃguez-Otero, Paula Siegel, David S. Nguyen, Tuong Vi Micco, Antonia Di Amin, Alpesh Chen, Min Kueenburg, Elisabeth van de Donk, Niels W.C.J.